FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

49616005: Monoclonal antibody (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
82640015 Monoclonal antibody en Synonym Active Entire term case insensitive SNOMED CT core module
787314018 Monoclonal antibody (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3779819014 Monoclonal protein en Synonym Active Entire term case insensitive SNOMED CT core module
3779820015 Monoclonal immunoglobulin en Synonym Active Entire term case insensitive SNOMED CT core module

150 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Monoclonal antibody Is a Non-organ specific antibody false Inferred relationship Existential restriction modifier
Monoclonal antibody Is a Antibody true Inferred relationship Existential restriction modifier
Monoclonal antibody Is a Monoclonal immunoglobulin false Inferred relationship Existential restriction modifier
Monoclonal antibody Is a Drug or medicament true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Bavencio 200mg/10ml concentrate for solution for infusion vials (Merck Serono Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Dupilumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Dupilumab 300mg/2ml solution for injection pre-filled syringes Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Dupixent 300mg/2ml solution for injection pre-filled syringes (Sanofi Genzyme) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Guselkumab Is a False Monoclonal antibody Inferred relationship Existential restriction modifier
Guselkumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Guselkumab 100mg/1ml solution for injection pre-filled syringes Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Tremfya 100mg/1ml solution for injection pre-filled syringes (Janssen-Cilag Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Benralizumab Is a False Monoclonal antibody Inferred relationship Existential restriction modifier
Ocrelizumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Ocrelizumab 300mg/10ml solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Ocrevus 300mg/10ml concentrate for solution for infusion vials (Roche Products Ltd) Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Emicizumab Is a False Monoclonal antibody Inferred relationship Existential restriction modifier
Benralizumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Benralizumab 30mg/1ml solution for injection pre-filled syringes Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Fasenra 30mg/1ml solution for injection pre-filled syringes (AstraZeneca UK Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Ocrevus 300mg/10ml concentrate for solution for infusion vials (Roche Products Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Burosumab Is a False Monoclonal antibody Inferred relationship Existential restriction modifier
Erenumab Is a False Monoclonal antibody Inferred relationship Existential restriction modifier
Dinutuximab beta Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Dinutuximab beta 20mg/4.5ml solution for infusion vials Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Qarziba 20mg/4.5ml concentrate for solution for infusion vials (EUSA Pharma (UK) Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Erenumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Erenumab 70mg/1ml solution for injection pre-filled disposable devices Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Aimovig 70mg/1ml solution for injection pre-filled pens (Novartis Pharmaceuticals UK Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Burosumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Burosumab 10mg/1ml solution for injection vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Burosumab 20mg/1ml solution for injection vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Burosumab 30mg/1ml solution for injection vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Crysvita 10mg/1ml solution for injection vials (Kyowa Kirin Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Crysvita 20mg/1ml solution for injection vials (Kyowa Kirin Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Crysvita 30mg/1ml solution for injection vials (Kyowa Kirin Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Guselkumab 100mg/1ml solution for injection pre-filled disposable devices Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Tremfya 100mg/1ml solution for injection pre-filled pens (Janssen-Cilag Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Tildrakizumab Is a False Monoclonal antibody Inferred relationship Existential restriction modifier
Tildrakizumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Tildrakizumab 100mg/1ml solution for injection pre-filled syringes Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Ilumetri 100mg/1ml solution for injection pre-filled syringes (Almirall Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Galcanezumab Is a False Monoclonal antibody Inferred relationship Existential restriction modifier
Keytruda 50mg powder for concentrate for solution for infusion vials (Originalis B.V.) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Perjeta 420mg/14ml concentrate for solution for infusion vials (Originalis B.V.) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Yervoy 50mg/10ml concentrate for solution for infusion vials (Originalis B.V.) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Burosumab Is a True Monoclonal antibody Inferred relationship Existential restriction modifier

Start Previous Page 5 of 5

This concept is not in any reference sets

Back to Start